CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
J-Plasmadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02658851
NCT02658851N/ACompleted
CompareCT.gov

Application of Cold Plasma Energy for Reduction of Lymphoceles Following Pelvic Lymph Node Dissection During Robot-Assisted Radical Prostatectomy

Apyx Medical·interventional·Posted Jan 20, 2016·Updated Dec 2, 2020

In Brief

A clinical study evaluating J-Plasma for Lymphoceles Following Pelvic Lymph Node Dissection. Completed, enrolled 100 participants across 1 site.

Detailed Summary

This study protocol will evaluate the efficacy of Bovie Medical's J-Plasma® helium based plasma technology in the reduction of lymphoceles following pelvic lymph node dissection (PLND) during robotic assisted radical prostatectomy (RARP). The J-Plasma® handpiece will be used during the PLND by dissecting the lymph nodes and sealing the lymphatic channels to prevent lymph leakage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphoceles Following Pelvic Lymph Node Dissection
CountriesUnited States
CollaboratorsAdventHealth

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 20, 2016
Enrollment StartJun 1, 2016
Primary CompletionJun 27, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.5 years ago

Interventions

J-Plasmadevice

Bovie Medical Corporation's J-Plasma® helium based plasma technology is a hemostatic tool for the cutting, coagulation, and ablation of soft tissue.